POINT BIOPHARMA GLOBAL INC. Stock-Based Compensation
POINT BIOPHARMA GLOBAL INC. reported Stock-Based Compensation of $4.60 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2023-11-13
- POINT BIOPHARMA GLOBAL INC. share-based payment arrangement, noncash expense for the quarter ending 2023-09-30 was $1.88M, a 73.90% increase year-over-year.
- POINT BIOPHARMA GLOBAL INC. share-based payment arrangement, noncash expense for the quarter ending 2023-06-30 was $1.71M, a 66.45% increase year-over-year.
- POINT BIOPHARMA GLOBAL INC. share-based payment arrangement, noncash expense for the quarter ending 2023-03-31 was $1.01M, a 129.20% increase year-over-year.
- POINT BIOPHARMA GLOBAL INC. share-based payment arrangement, noncash expense for the quarter ending 2022-12-31 was $998.53K, a 169.30% increase year-over-year.
- POINT BIOPHARMA GLOBAL INC. share-based payment arrangement, noncash expense for fiscal 2022 was $3.55M, a 53.98% increase from fiscal 2021.
- POINT BIOPHARMA GLOBAL INC. share-based payment arrangement, noncash expense for fiscal 2021 was $2.30M, a 30.77% increase from fiscal 2020.
- POINT BIOPHARMA GLOBAL INC. share-based payment arrangement, noncash expense for fiscal 2020 was $1.76M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | $1.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $3.59M derived: sum of 2 quarters · filed 2023-11-13 | $4.60M 10-Q · filed 2023-11-13 | $5.59M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | $1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $2.72M 10-Q · filed 2023-08-14 | $3.72M derived: sum of 3 quarters · filed 2023-08-14 | $4.80M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-03-31 | $1.01M 10-Q · filed 2023-05-15 | $2.01M derived: sum of 2 quarters · filed 2023-05-15 | $3.09M derived: sum of 3 quarters · filed 2023-11-13 | $4.11M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-12-31 | $998.53K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $2.08M derived: sum of 2 quarters · filed 2023-11-13 | $3.11M derived: sum of 3 quarters · filed 2023-11-13 | $3.55M 10-K · filed 2023-03-27 |
| 2022-09-30 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $2.11M derived: sum of 2 quarters · filed 2023-11-13 | $2.55M 10-Q · filed 2023-11-13 | $2.92M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.47M 10-Q · filed 2023-08-14 | $1.84M derived: sum of 3 quarters · filed 2023-08-14 | $2.19M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $440.45K 10-Q · filed 2023-05-15 | $811.24K derived: sum of 2 quarters · filed 2023-05-15 | $1.16M derived: sum of 3 quarters · filed 2023-05-15 | $2.27M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $370.79K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $718.90K derived: sum of 2 quarters · filed 2023-03-27 | $1.83M derived: sum of 3 quarters · filed 2023-03-27 | $2.30M 10-K · filed 2023-03-27 |
| 2021-09-30 | $348.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.45M derived: sum of 2 quarters · filed 2022-11-14 | $1.93M 10-Q · filed 2022-11-14 | $2.07M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $1.58M 10-Q · filed 2022-08-12 | $1.73M derived: sum of 3 quarters · filed 2022-08-12 | $2.13M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $477.25K 10-Q · filed 2022-05-13 | $619.00K derived: sum of 2 quarters · filed 2022-05-13 | $1.02M derived: sum of 3 quarters · filed 2022-05-13 | |
| 2020-12-31 | $141.76K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $545.75K derived: sum of 2 quarters · filed 2022-03-25 | $1.76M 10-K · filed 2022-03-25 | |
| 2020-09-30 | $404.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.62M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $1.22M 10-Q · filed 2021-08-13 |